Physician profile

Steven M Erickson

Sports Medicine (Internal Medicine) · Phoenix, AZ

NPI 1215998901

$302.67

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$140.71

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bioventus LLC $63.36 2022-2024 Exogen Ultrasound Bone Healing System, Durolane
Stryker Corporation $57.53 2023 Aequalis Perform Reversed
Djo, LLC $37.23 2022
Ferring Pharmaceuticals INC. $36.14 2023 Euflexxa
Impactortho, INC. $27.45 2022
Relievant Medsystems, INC. $23.75 2020
Orthofix Medical, INC. $23.49 2020
Kci USA, INC. $19.61 2022
My01 INC. $14.11 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steven M Erickson

$302.67

in general payments reported 2019-2025

Years
2020-2024
Top company
Bioventus LLC

https://glasscript.com/doctor/910111/steven-m-erickson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.